ERGO.L Forecast and Technical Stock Analysis
Buy candidate since 2019-08-07 Loss -0.31%
No changes to the price of Entia Biosciences Inc in the last trading day ( Thursday, 22nd Aug 2019 ). During the day the stock fluctuated 5.59% from a day low at £3.22 to a day high of £3.40. The price has been going up and down for this period, and there has been a -0.31% loss for the last 2 weeks.
- 30 day high of the ERGO.L stock price was £3.40 and low was £3.18.
- 90 day high was £3.40 and low was £2.19.
- 52 week high for Entia Biosciences Inc - £187.00 and low - £1.45.
Entia Biosciences Inc lies in the lower part of a wide and strong rising trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at £3.14 will firstly indicate a slower raising rate, but may also be a early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 35.34% during the next 3 months and, with 90% probability hold a price between £4.25 and £5.06 at the end of this period.
Entia Biosciences Inc holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately £3.23. On a fall, the stock will find some support from the long-term average at approximately £3.10. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. Volume gained on the last day while the price remained unchanged. This is not a classical divergence, but the stock should be watched more closely at it may be a "turning point". The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Monday August 05, 2019, which indicates further falls until a new bottom pivot has been found.
Relative Strength Index (RSI)
RSImin/max Values: [ 15 - 85 ]
RSI14 is 50 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
On the downside, the stock finds support just below today's level from accumulated volume at £3.03 and £2.93.
There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Entia Biosciences Inc finds support just below today's level at £3.03. If this is broken, then the next support from accumulated volume will be at £2.93 and £2.73.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved £0.18 (5.59%) between high and low. For the last week, the stock has had daily average volatility of 2.50%.
Our recommended stop-loss: £3.10 (-4.11%) (This stock has low daily movements and this gives low risk. There is a sell signal from pivot top found 13 day(s) ago.)
2.50 %Average volatility
Very Low Low Medium High Very High
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!